Delivery Order SPE2DB20D7066-SPE2DB25FC2BX

Award Date 1/17/25
Potential Completion Date 1/21/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,052.45, is for the delivery of XYLOCAINE-MPF 2% 100 MG/5 ML 5ML, a medical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of March 6, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This federal contract award, with ID SPE2DX15D1104|SPE2DX24F3FH9, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,037.22 firm fixed-price delivery order is for the pharmaceutical product XYLOCAINE-MPF 2% VIAL 5ML, with an ultimate completion date of October 27, 2023. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a local anesthetic medication. The $3,635.91 Firm Fixed Price contract is a Delivery Order that has an ultimate completion date of April 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $2,536.32. The order is for the supply of XYLOCAINE-MPF 2% VIAL 2ML, a local anesthetic medication. The contract has a firm fixed price pricing type and an ultimate completion date of August 26, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.11 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a pharmaceutical product, with a period of performance ending on October 31, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, identified as SPE2DX15D7057|SPE2DX24FLCEW, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract, which is not set aside, is for the delivery of XYLOCAINE-MPF 1% VIAL 30ML, a pharmaceutical product. The award has a ceiling value of $1,487.42 and a completion date of August 2, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical...
This federal contract award, with a ceiling value of $2,054.88, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4559068759 - XYLOCAINE-MPF 2% AMPUL 10ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
The federal contract award SPE2DX15D6038|SPE2DX25F2AJ2 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,458.52 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 1% VIAL 30ML medical products. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of XYLOCAINE-MPF 2% 100 MG/5 ML 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,136.02, is a Firm Fixed Price Delivery Order with a completion date of June 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,360.00 firm fixed-price delivery order (SPE2DB20D3103|SPE2DB24FQ1W8) is for the supply of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a prescription medication. The contract has a completion date of September 9, 2024 and was awarded on September 6, 2024. There is no set-aside designation for this...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC2BX
    Delivery Order

This federal contract award, with an ID of SPE2DB20D7066|SPE2DB25FC2BX, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a pharmaceutical product, with a ceiling value of $1,466.93 and a completion date of January 21, 2025. The contract type is Delivery Order with a Firm Fixed Price pricing mechanism. This award is not associated with a set-aside program and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/21/25, 9:56 AM